SCHEMBL1879488

SCHEMBL1879488

CCCCOC(=O)CC(OCCCC)OCCCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.48
ALDH1A1 P00352 1/20 0.48
ATM Q13315 1/20 0.45
DGKA P23743 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
MAPK1 P28482 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 4/20 0.42
HPGD P15428 1/20 0.42
RAD52 P43351 1/20 0.42
LMNA P02545 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
FAAH O00519 1/20 0.41
ESR1 P03372 1/20 0.41
CYP2D6 P10635 1/20 0.41
NR1H2 P55055 1/20 0.41
RNASEL Q05823 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1879519 0.96 NAAA (0.44) NAAAALDH1A1ATMDGKANPSR1
SCHEMBL8944129 0.91 NAAA (0.42) NAAAALDH1A1ATMDGKANPSR1
SCHEMBL1884754 0.90 NAAA (0.47) NAAAALDH1A1ATMDGKANPSR1
SCHEMBL1879615 0.90 ALDH1A1 (0.42) NAAAALDH1A1ATMDGKANPSR1
SCHEMBL1883903 0.85 MAPT (0.41) NAAAALDH1A1ATMDGKAMAPT
SCHEMBL11090336 0.85 NAAA (0.39) NAAAALDH1A1DGKANPSR1MAPK1
SCHEMBL1879588 0.84 NAAA (0.48) NAAAALDH1A1ATMDGKANPSR1
SCHEMBL1883376 0.84 CA12 (0.41) NAAAALDH1A1ATMDGKATSHR
SCHEMBL11571805 0.82 NAAA (0.47) NAAAALDH1A1ATMDGKANPSR1
SCHEMBL29077537 0.82 NAAA (0.47) NAAAALDH1A1ATMDGKANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1666440-B1 METHOD FOR PRODUCING AROMATIC UNSATURATED COMPOUND SUMITOMO CHEMICAL CO (JP) 2014-01-22 EP disclosed
US-7939674-B2 Process for producing an aromatic unsaturated compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-10 US disclosed
US-7700642-B2 Process for producing an aromatic unsaturated compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-20 US disclosed
US-20090111999-A1 PROCESS FOR PRODUCING AN AROMATIC UNSATURATED COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-30 US disclosed
US-20080221337-A1 Process for Producing an Aromatic Unsaturated Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-09-11 US disclosed
EP-1666440-A1 METHOD FOR PRODUCING AROMATIC UNSATURATED COMPOUND Sumitomo Chemical Company, Limited (JP) 2006-06-07 EP disclosed
US-4440928-A Process for preparation of uracils UBE INDUSTRIES, LTD. (JP) 1984-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221337-A1 Process for Producing an Aromatic Unsaturated Compound AHR, AR, ARSA NAAA 338/4885ALDH1A1 231/4885ATM 2405/4885
US-20090111999-A1 PROCESS FOR PRODUCING AN AROMATIC UNSATURATED COMPOUND AHR, AR, ARSA NAAA 338/4885ALDH1A1 231/4885ATM 2405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.